IDEAYA Biosciences (IDYA) Cash from Operations (2018 - 2026)

IDEAYA Biosciences has disclosed Cash from Operations across 9 years of filings, most recently posting 75170000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 75170000.0, down 24.57% year-over-year; the trailing twelve-month figure through Mar 2026 was 85926000.0 (up 67.47% YoY), and the FY2025 annual result was 71098000.0, up 71.28% from the prior year.
• Cash from Operations came in at 75170000.0 for Q1 2026 at IDEAYA Biosciences, up from 90496000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 142214000.0 in Q3 2025 to a low of 121655000.0 in Q4 2024.
• The 5-year median for Cash from Operations is 32882000.0 (2024), against an average of 35073588.24.
• Across the five-year window, Cash from Operations slumped 412.27% in 2024 and jumped 388.85% in 2025, its largest moves.
• IDEAYA Biosciences' Cash from Operations stood at 23370000.0 in 2022, then decreased by 1.62% to 23748000.0 in 2023, then plunged by 412.27% to 121655000.0 in 2024, then gained by 25.61% to 90496000.0 in 2025, then gained by 16.94% to 75170000.0 in 2026.
• The last three Cash from Operations figures came in at 75170000.0 (Q1 2026), 90496000.0 (Q4 2025), and 142214000.0 (Q3 2025), per Business Quant data.